By Michael Gwarisa Zimbabwe has become the third African country to receive doses of injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention after Malawi and Zambia in a move that is set to expand HIV prevention methods for Zimbabweans. The injectable cabotegravir for HIV PrEP will be administered by healthcare providers. Initially, a person receives an intramuscular (IM) injection of cabotegravir one time each month for the first two months. After that,a person will receive an IM injection of cabotegravir one time every two months. Speaking in an…
Read More#BREAKING: Zimbabwe Receives 2000 Doses Of Injectable PrEP
